Overview

The follicle stimulating hormone (FSH) test kit built on a colloidal gold immunochromatographic method is an in vitro diagnostic medical device. Before a distributor can move a shipment across a border, the product must be classified under the local IVD framework, registered with the competent authority, and accompanied by documentation that satisfies customs. The classification step is the foundation of everything that follows, because it determines which conformity assessment route applies.

In major regulatory systems, an FSH lateral-flow kit used at the point of care typically falls into a moderate-risk IVD class. Under the European IVDR, such devices generally require self-certification or notified-body involvement depending on the intended purpose and risk rules. In the United States, an FSH test may be marketed under a 510(k) clearance if a substantially equivalent predicate exists, or under a CLIA waiver if the kit is intended for use in waived settings.

Step-by-Step Regulatory Path

The first step is to confirm the kit's intended purpose statement and the manufacturer's conformity evidence. The buyer should request the declaration of conformity, the technical file summary, and any certificates issued by an accredited body. These documents travel with the shipment and are inspected at customs.

The second step is registration in the destination country. Some authorities require an in-country authorisation holder, so the foreign manufacturer must appoint a local distributor or authorised representative before the goods can be released. Label and instructions for use must be localised, which often requires translation of the IFU and adjustment of symbols to the local standard.

The third step is customs clearance itself. Import HS codes for IVDs are jurisdiction-specific, but a typical declaration includes the product description, the manufacturer's details, the batch or lot number, the quantity and the value. Some authorities require an import licence or a free-sale certificate from the country of origin. Documentation gaps at this stage are the most common cause of detained shipments.

Post-Market Obligations

Once the kit is on the market, the local authorisation holder must maintain a post-market surveillance system. Field safety corrective actions issued by the manufacturer must be communicated to users in line with local timelines. Adverse events related to false results, particularly false negatives in fertility assessments, are reportable. Periodic safety update reports or equivalent summaries may be required by the authority.

FAQ

Q: What is the first document a customs broker will ask for? A: The declaration of conformity or 510(k) clearance letter, together with the invoice, packing list and the locally required import licence.

Q: Does the IFU have to be in the local language? A: In most jurisdictions the IFU must be supplied in the official language or languages of the destination market at the time of release.

Q: Who acts as the legal authorisation holder? A: In many markets the local distributor or an authorised representative accepts this role and is responsible for post-market duties.

Q: How are batch-specific issues handled after release? A: The manufacturer issues a field safety notice or recall; the local holder communicates it to users and reports to the competent authority within the prescribed window.